|
Dr. Watson was a co-founder of Beacon BioPartners, LLC, a strategic and business development consultancy for biotechnology/Life Sciences companies. Prior to Beacon, she was Director of Business Development for Pyrosequencing AB, a biotechnology company that developed, manufactured and sold genetic analysis instrumentation and consumable products for the Life Sciences market. Dr. Watson was Vice President at Feinstein Kean Healthcare (an Ogilvy Public Relations subsidiary), a communications and business consultancy that specialized in scientific communications, and assisting biotechnology companies with corporate strategy to support financing and partnering activities. Dr. Watson was a postdoctoral fellow at Harvard University, where her research focused protein biochemistry and molecular genetic approaches to interrogate signal transduction pathways important in cancer. She has a Ph.D. from the University of California, Irvine, a M.S. degree from Kansas State University and a B.Sc. Honours degree from Queens University. | 